Over the past few weeks, the FDA has devoted lots of attention to compounding pharmacies, issuing two new guidance documents pertaining to their fundamental scope, a guidance document regarding ...

This post is inspired by the presentation by Kaushik Punjabi at London Value Investing Club. The content of the post, however, is the view of the author. We always hear we should start to save for ...

Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

The compounding pharmacy market, valued at approximately USD 15.1 billion in 2025, is forecast to reach nearly USD 20 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7%, says ...

The infection came out of nowhere, 36 hours after Eloise Soler's heart surgery last summer at the Corpus Christi Medical Center in South Texas. As her fever spiked to 103, other patients developed ...

Following Hims & Hers’ Super Bowl ad for its weight loss product, a debate has emerged over the safety of compounded GLP-1s for patients. Compounded GLP-1s are custom-made by compounding pharmacies ...